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It is widely accepted that  dietary sugars promote  adverse metabolic  outcomes via weight-gain through  their contribution to energy 
intake.  Emerging  evidence suggests that  dietary  sugars are associated  with adverse metabolic  outcomes  including increased  blood 
pressure and  serum lipids, independently  of energy intake  and  body-weight(1).  However,  dietary  sugars are a complex component 
of the diet and their effects on health outcomes are likely to differ depending on the properties  of the consumed sugars. Therefore, 
associations  between dietary sugars and metabolic and inﬂammatory markers  may vary according  to whether sugars are from bev- 
erage or food sources and, extrinsic or intrinsic. 
The aim of this study was to examine the association  between intakes of dietary sugars from different sources and metabolic and 
inﬂammatory markers using a population-based cross-sectional study of adults in the East of England. Sugar intakes from beverages 
(liquids),  foods  (solids), extrinsic  (free sugars)  or  intrinsic  (non-free  sugars)  were estimated  using food  frequency  questionnaires. 
Glycated haemoglobin,  glucose, insulin, and C-Reactive Protein (CRP) were measured in fasting blood samples and insulin resistance 
(HOMA-IR) and a continuous  metabolic risk z-score were derived. 
The contributions to total energy intake (TEI) of sugars from liquids, solids, free sugars and non-free sugars contributed  2·9 %, 20·0 %, 
12·0 % and 11·6 % respectively. In multiple linear regression analyses adjusted  for age, sex, socio-economic status, smoking status, al- 
cohol consumption, physical activity, clinical history, BMI, TEI, dietary quality, fat intake and sugars from other sources, and corrected 
for multiple testing, sugars from liquids (per 10 %TEI) were positively associated  with ln-CRP  [β-coefﬁcient(95 %CI), 0·14(0·05,0·22)] 
and the metabolic risk z-score [0·13(0·07,0·18)]. Free sugars were positively associated with ln-HOMA-IR [0·05(0·03,0·08)] and the meta- 
bolic risk z-score [0·09(0·06,0·12)]. Sugars from solids were not associated with any outcome.  Among major food and beverage contri- 
butors to intake, sugars (per 10 %TEI) in fruit, vegetables, dairy products/egg dishes, cakes/biscuits/confectionary and fruit squash/juice 
drinks were not associated, but sugar added to tea, coffee, cereal was signiﬁcantly positively associated with all outcomes. Sugars in 100 
% fruit juice [0·16(0·06,0·25)] and other non-alcoholic  beverages [0·13(0·03,0·23)] and metabolic risk z-score were positively associated. 
In conclusion, higher intakes of sugars from non-alcoholic  beverages and sugar added  to tea, coffee, cereal were associated with 
glycaemia and inﬂammatory markers. Sugars from solids were not associated, irrespective of whether they were intrinsic or extrinsic. 
The positive associations  of free sugars were largely explained by the contribution of beverages to intake. Adverse metabolic conse- 
quences of sugar intake,  independent  of contribution to caloric intake, may be attributable to sugar intake from beverages. 
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